135 related articles for article (PubMed ID: 22582841)
1. Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection.
Gisbert JP;
Aliment Pharmacol Ther; 2012 Jun; 35(12):1484-5; author reply 1486. PubMed ID: 22582841
[No Abstract] [Full Text] [Related]
2. Reflux masquerader: acute Helicobacter pylori infection in neonates and infants.
Frem JC; Gold BD; Shehata BM; Cole CR
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):589-92. PubMed ID: 18493216
[No Abstract] [Full Text] [Related]
3. Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
Gisbert JP; McNicholl AG
Helicobacter; 2012 Apr; 17(2):160-1. PubMed ID: 22404448
[No Abstract] [Full Text] [Related]
4. [Effectiveness and safety of proton pump inhibitor and levofloxacin based first-line triple therapy in the eradication of Helicobacter pylori: a meta-analysis].
Zhang ZF; Zhao G; Liu LN
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2722-5. PubMed ID: 19080698
[TBL] [Abstract][Full Text] [Related]
5. Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Rokkas T; Sechopoulos P; Robotis J; Pistiolas D
Am J Gastroenterol; 2006 Aug; 101(8):1938; author reply 1938-9. PubMed ID: 16928256
[No Abstract] [Full Text] [Related]
6. Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.
Pellicano R; Astegiano M; Smedile A; Saracco G; Berrutti M; Morgando A; Fadda M; Repici A; Fagoonee S; Rizzetto M
Panminerva Med; 2008 Sep; 50(3):259-60. PubMed ID: 18927531
[No Abstract] [Full Text] [Related]
7. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
[TBL] [Abstract][Full Text] [Related]
8. [New options for helicobacter pylori antibiotic treatment].
Misselwitz B; Kaiser P; Bauerfeind P; Vavricka SR
Dtsch Med Wochenschr; 2011 Jul; 136(28-29):1479-84. PubMed ID: 21732262
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence?
Yuan Y; Thabane L; Hunt RH
Aliment Pharmacol Ther; 2006 Apr; 23(8):1283-5; author reply 1285-6. PubMed ID: 16611298
[No Abstract] [Full Text] [Related]
10. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Gisbert JP; Gisbert JL; Marcos S; Pajares JM
Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
[TBL] [Abstract][Full Text] [Related]
11. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
[TBL] [Abstract][Full Text] [Related]
12. [Rescue therapy after Helicobacter pylori eradication failure].
Gisbert JP
Gastroenterol Hepatol; 2011 Feb; 34(2):89-99. PubMed ID: 21371619
[TBL] [Abstract][Full Text] [Related]
13. Levofloxacin in first-line treatment of Helicobacter pylori infection.
Rispo A; Di Girolamo E; Cozzolino A; Bozzi R; Morante A; Pasquale L
Helicobacter; 2007 Aug; 12(4):364-5. PubMed ID: 17669111
[No Abstract] [Full Text] [Related]
14. H. pylori should be eradicated in chronic liver disease patients with peptic ulcer.
Zullo A; Cristofari F; Hassan C
Dig Liver Dis; 2009 Feb; 41(2):141-2. PubMed ID: 19112053
[No Abstract] [Full Text] [Related]
15. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
Cheng HC; Chang WL; Chen WY; Yang HB; Wu JJ; Sheu BS
Helicobacter; 2007 Aug; 12(4):359-63. PubMed ID: 17669110
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.
Liou JM; Lin JT; Chang CY; Chen MJ; Cheng TY; Lee YC; Chen CC; Sheng WH; Wang HP; Wu MS
Gut; 2010 May; 59(5):572-8. PubMed ID: 20427390
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
Molina-Infante J; Perez-Gallardo B; Fernandez-Bermejo M; Hernandez-Alonso M; Vinagre G; Dueñas C; Mateos-Rodriguez JM; Gonzalez-Garcia G; Abadia EG; Gisbert JP
Aliment Pharmacol Ther; 2010 May; 31(10):1077-84. PubMed ID: 20180787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
